David Alan Campbell, President and CEO: Janux Therapeutics JANX Sell · Filed 24/10/30

Trade details

Type: Insider sale
Amount: $739,598.34
Shares · price: 13,897 sh · $53.22 a share
Held after: 293,157 sh
Stock: Janux Therapeutics JANX
Person: David Alan CampbellPresident and CEO
Trade date: 24/10/28
Filed: 24/10/30
Days to filing: 2 days

Sold 4.5% of holdings

Share of holding sold: 4.5%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/28~24/11/27

David Alan Campbell's recent trades

David Alan CampbellPresident and CEO
SellJanux Therapeutics
Sell
Janux Therapeutics
JANX
$110.8K
8,072 sh
$110.8K
Filed 01/02
Traded 01/02
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$300K
5,000 sh
$300K
Filed 25/01/08
Traded 25/01/07
David Alan CampbellOfficer
Planned sale10b5-1 planJanux Therapeutics
Planned sale10b5-1 plan
Janux Therapeutics
JANX
$300K
5,000 sh
$300K
Filed 25/01/07
Traded 25/01/07
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$1.4M
25,000 sh
$1.4M
Filed 24/12/27
Traded 24/12/24
David Alan CampbellPresident and CEO
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$1M
15,000 sh
$1M
Filed 24/12/03
Traded 24/12/03

David Alan Campbell, CEO — sold $739.6K of Janux Therapeutics JANX · 4.5% of holdings · 10b5-1 plan | Whalegun